Fig. 6From: Upregulation of CALD1 predicted a poor prognosis for platinum-treated ovarian cancer and revealed it as a potential therapeutic resistance targetThe Immunohistochemistry (IHC) of CALD1 in different kinds of OC and corresponding normal tissues based on the Human Protein Atlas (HPA). A Normal ovarian tissue (Staining: High; Intensity: Strong; Quantity: > 75%). B Ovarian serous cystadenocarcinoma (Staining: High; Intensity: Strong; Quantity: > 75%). C Ovarian mucinous cystadenocarcinoma (Staining: High; Intensity: Strong; Quantity: > 75%). D Endometroid carcinoma of ovary (Staining: Medium; Intensity: Moderate; Quantity: 75%-25%)Back to article page